Editorial Type: Case Reports
 | 
Online Publication Date: 01 Sept 2004

Pigmented Epidermal Plaques in Three Dogs

PhD, DVM,
DVM, PhD, Diplomate ACVP,
DVM, PhD, Diplomate ACVP, and
DVM, MS, Diplomate ACVD, Diplomate ACVIM
Article Category: Other
Page Range: 411 – 417
DOI: 10.5326/0400411
Save
Download PDF

Papillomavirus was identified in pigmented epidermal plaques (PEP) from three dogs: a miniature schnauzer with hyperadrenocorticism and hypoglobulinemia, an American Staffordshire terrier with hypoglobulinemia, and a Pomeranian with unconfirmed hypothyroidism. Squamous cell carcinoma (SCC) arose within several plaques in the Pomeranian. Clinical improvement coincided in the first two cases with treatment of the concurrent disease and the administration of low-dose oral interferon-α. This is the first report of PEP in an American Staffordshire terrier and a Pomeranian. The potential for malignant transformation of PEP to SCC emphasizes the need for recognition and clinical management of PEP.

Introduction

Pigmented epidermal plaques (PEP) have been reported as a condition in the pug, miniature schnauzer, Chinese shar pei, and in individual cases of an English setter and an English pointer.1–5 Affected dogs have multiple cutaneous macules, papules, and plaques of heavily pigmented hyper-plastic epidermis. The dark pigmentation in the lesions results from an abnormal distribution of melanin within the epidermis and an accumulation of melanin in melanophages, rather than from a proliferation of melanocytes. Earlier designations that implied melanocytic hyperplasia, such as lentiginosis profusa, are no longer used.36 Ultrastructural studies of PEP have identified intranuclear inclusion bodies compatible with papillomavirus.3

Pigmented epidermal plaques in dogs may be analogous to epidermodysplasia verruciformis in humans, in which several closely related papillomaviruses cause a generalized distribution of pink to brown macules and verrucous papules and plaques.37–21 Although the viruses that cause epidermodysplasia verruciformis are widespread in the human population, active infections that result in the development of disease are rare.79 An X-linked or autosomal genetic predisposition associated with at least two genes on separate chromosomes leads to increased susceptibility to this group of viruses and the development of disease in predisposed individuals.22 In addition, renal transplant patients and other immunosuppressed individuals that are not members of genetically predisposed groups have a substantially higher incidence of epidermodysplasia verruciformis than the general population.23–26 Development of epidermodysplasia verruciformis in these latter individuals is attributed to defects in cell-mediated immunity and local mechanisms of immune surveillance secondary to their immuno-suppression.1923–27 The plaques in half of epidermodysplasia verruciformis-affected humans undergo malignant transformation to squamous cell carcinoma (SCC) or other nonmelanocytic skin cancers in sun-exposed sites.89131624252829 Although approximately 18 types of human papillomaviruses have been identified in epidermodysplasia verruciformis lesions, most neoplasms are associated only with human papillomavirus-5.912132123243031

This report presents cases of PEP from a miniature schnauzer with hyperadrenocorticism, an immunoglobulin-deficient American Staffordshire terrier, and a Pomeranian with unconfirmed hypothyroidism in which SCC arose by malignant transformation within multiple plaques. Papillomavirus was identified in plaques from all three animals.

Case Reports

Case No. 1

An 11.8-kg, 10-year-old, spayed female miniature schnauzer was presented to the University of Illinois Veterinary Teaching Hospital (UI-VTH) with a 2-year history of pigmented plaques on the flanks and dorsal thorax [Figure 1]. Both the number and size of the plaques had increased during the several months prior to presentation. Multiple, darkly pigmented macules and plaques involved the skin caudal to the dog’s right ear, the interscapular area, over the thoracolumbar spine, at the base of the tail, over both flanks, and on the ventral thorax, abdomen, and groin. The plaques ranged in diameter from 2 to 25 mm and in height from macular to 5 mm. They had a rough surface, a waxy texture, and were friable. Multiple superficial and deep skin scrapings were negative for mites and ova. Impression smears of the plaques and adjacent skin contained no bacteria or Malassezia spp. The abdomen was pendulous, and the dog had gradually become polyphagic and polyuric, but the owner could not state when those signs first appeared.

A complete blood count (CBC), total thyroxine (T4), and thyroid-stimulating hormone (TSH) concentrations were within reference ranges. Elevations of serum alkaline phosphatase (SAP, 572 U/L; reference range, 12 to 110 U/L) and the corticosteroid-induced isoform of SAP (501 U/L; reference range, 0 to 40 U/L) were detected. Thoracic radiographs were unremarkable. On abdominal ultrasonography, neither adrenal gland was enlarged (left, 4.8-mm thickness on caudal pole; right, 5.2-mm thickness on caudal pole; reference range, 4 to 7 mm). Baseline serum cortisol was elevated at 221 nmol/L (reference range, 58 to 144 nmol/L). Two hours after administration of corticotropin (ACTH) gela (2.2 IU/kg intramuscularly), serum cortisol increased to 576 nmol/L (2-hour post-ACTH reference range, 186 to 566 nmol/L). Cortisol was suppressed 8 hours after administration of dexamethasone (0.01 mg/kg intravenously) to 27.6 nmol/L (8-hour post-dexamethasone reference range, 0 to 42 nmol/L). Serum immunoglobulin concentrations were measured, and all were below reference ranges. Immunoglobulin G (IgG) was 923 mg/dL (reference range, 1000 to 2000 mg/dL); immunoglobulin A (IgA) was 8 mg/dL (reference range, 20 to 150 mg/dL); and immunoglobulin M (IgM) was 15 mg/dL (reference range, 70 to 270 mg/dL).

Full-thickness, 6 mm-diameter punch biopsies of papules and plaques were obtained using local anesthesia. Tissues were fixed in 10% neutral-buffered formalin for light microscopy, and additional 2-mm samples were immersed in Karnovsky’s fixative (2.5% glutaraldehyde with 2% paraformaldehyde) buffered with 0.1 molar phosphate for transmission electron microscopy (TEM).3 Some sections from formalin-fixed blocks were assayed by immunohistochemistry for papillomavirus group-specific antigen. Papillomavirus controls were sections of normal canine skin (negative) and sections from canine oral papilloma (positive).

On histopathology, the plaques were hyperkeratotic and exophytic. The epidermal surface had numerous papilliferous folds [Figure 2], with an abrupt change from normal to affected epidermis. The epidermis was heavily pigmented, with melanin present in epidermocytes. Melanocytes did not appear increased in number. Pigment was present within keratinocytes in all cell layers of the epidermis, and dermal pigmentary incontinence was prominent. Although all epidermal layers were thickened, the most dramatic changes affected the stratum granulosum. Cells in the stratum granulosum contained large, keratohyalin-like granules that often obscured the nuclei. Rare cells of this layer contained smudged, intranuclear inclusion bodies. The superficial dermis contained prominent interstitial melanophages along with occasional scattered lymphocytes and plasma cells. Scattered nuclei within epidermal plaques exhibited immunoreactivity for papillomavirus group-specific antigen.

Transmission electron microscopy revealed intranuclear inclusion bodies within the stratum granulosum cells. Particles within the inclusion were arranged in a crystalline array [Figure 3]. At higher magnification, the particles were hexagonal and 25 to 30 nm in diameter. The organization, size, and shape of the particles were consistent with papillomavirus.

To control the animal’s hyperadrenocorticism, oral mitotaneb was initiated at a dose of 35 mg/kg q 12 hours for 5 days, after which baseline cortisol was 149 nmol/L and post-stimulation cortisol was 307 nmol/L. Polyphagia, polydipsia, and polyuria decreased. Mitotane was administered at the same dose, three times weekly for 4 weeks, at which time baseline cortisol was 76.9 nmol/L and post-stimulation cortisol was 219 nmol/L. No new plaques developed after initiation of mitotane therapy, and the texture of existing plaques became less waxy. The dog was then given a maintenance dosage of mitotane (35 mg/kg q 12 hours 2 days per week). Interferon-α 2Ac (IFN-α 2A) was also prescribed (1000 IU per os [PO] on a 21-day on, 7-day off schedule). Most plaques over the dog’s dorsal thorax resolved completely, and few new plaques developed over a 2-year period.

Case No. 2

A 22-kg, 3-year-old, spayed female, white and fawn American Staffordshire terrier was presented to the UI-VTH with multiple pigmented plaques ranging in diameter from 2 to 20 mm on the inner aspects of the apices of both ear pinnae. The first plaque was observed on the inner apex of the left ear 2 years prior to presentation. Additional papules and plaques developed on the inner aspects of the apices of both pinnae. Cytological examination of impression smears of interdigital skin from all four feet revealed Malassezia spp. Impression smears of skin from the left axilla contained cocci. The dog had a history of recurrent small intestinal bacterial overgrowth, inflammatory bowel disease, vaginitis, otitis, and pyoderma beginning at 4 months of age. Immunoglobulin levels measured when the dog was 7 months of age were below reference ranges (IgG, 801 mg/dL; IgA, 7 mg/dL; IgM, 60 mg/dL). Immunotherapy using a staphylococcal antigen-based immunomodulatord was initiated when the animal was 2 years of age; but after 1 year, this had not resulted in any clinical improvement.

Several pigmented plaques were removed by surgical excision with the dog under general anesthesia. Tissues were processed for light microscopy, immunohistochemistry, and TEM. Plaques were formed by localized, irregular thickening of the epidermis. All layers of the epidermis were thickened, and hyperkeratosis was marked. The epidermal cells of the stratum granulosum contained giant, irregular, keratohyalin-like granules that obscured nuclei. Hyperpigmentation was moderate, and mild pigmentary incontinence was present in the dermis. Multiple nuclei within epidermal plaques were immunoreactive for papillomavirus group-specific antigen. Stratum granulosum cells contained intranuclear inclusion bodies consistent with papillomavirus; they were similar in size, shape, and arrangement to those described for case no. 1.

The plaques were ablated using a carbon dioxide (CO2) laser, and IFN-α 2A was administered at the same dose used in case no. 1. No plaques had recurred at the laser ablation sites 18 months after the procedure. No new lesions had developed while the animal was on IFN therapy; however, small papules developed on the inner aspects of both ear pinnae when IFN was discontinued after 12 months because of financial constraints. Those plaques failed to resolve.

Case No. 3

A 4.9-kg, 8.5-year-old, spayed female Pomeranian was presented to the UI-VTH with a 4-year history of multiple, black, hyperkeratotic macules and plaques with friable, papillomatous projections. Erythematous, exudative, and ulcerative lesions developed within some plaques 7 months before presentation. Eighteen months prior to presentation, hypothyroidism was diagnosed by the referring veterinarian on the basis of low T4 values, although test results were unavailable. The owner reported a diminished rate of increase in plaque size and number coincident with administration of thyroid supplementation; however, existing plaques failed to regress. The referring veterinarian surgically removed plaques that had ulcerated and become invasive, and the microscopic diagnosis of several was SCC.

Physical examination at UI-VTH revealed multiple areas of hyperpigmentation and crusting that were most severe on the thorax, ventral abdomen, and groin. Abundant, friable, darkly pigmented, elevated, roughened, proliferative plaques ranging in diameter from 10 to 30 mm were present in the same area. A 10 mm-diameter, darkly pigmented, rough-surfaced macule lined the inner right pinna, and a hyperkeratotic pigmented plaque was on the inner left pinna. A 3 × 2-cm pigmented mass on the dog’s left upper lip adjacent to the nasal planum and a 5 × 2-cm mass extending from the dog’s right axilla to the medial aspect of the elbow were ulcerated. Results of a CBC, serum biochemical profile, and thoracic radiographs were unremarkable. Thyroid levels were not remeasured; thus, the diagnosis of hypothyroidism was not confirmed.

Biopsies of pigmented plaques from two sites on the caudal ventral abdomen, the left upper lip, and the right axilla were taken with the animal under general anesthesia. Tissues were processed for light microscopy and immunohistochemistry as described for case no. 1. Formalin-fixed tissues in paraffin-embedded blocks were deparaffinized using serial xylene washes, then they were post-fixed and processed for TEM.

The epidermis of a pigmented plaque from the skin over the abdomen was prominently folded, with significant retention of keratin over the skin surface. Histopathological features were similar to those described for case no. 1. No evidence of neoplasia was observed. Squamous cell carcinoma in situ was identified histopathologically in a second plaque in the skin over the abdomen. Arising within a pigmented plaque was a region of markedly thickened epidermis with mild disorganization and multifocal dyskeratosis. The integrity of the basement membrane remained intact. Plaque-like masses from the lip and right axilla contained poorly demarcated, highly infiltrative, nonencapsulated areas diagnosed as SCC [Figure 4]. The SCC arose within pigmented, hyperkeratotic plaques. The SCC consisted of numerous coalescing cords and nests of moderately to markedly atypical squamous epithelial cells that infiltrated the dermis and were associated with marked reactive fibrosis. Keratinization with the formation of keratin pearls was present centrally within nests. Lymphatic invasion was present.

Several keratinocytes in the peritumoral stratum granulosum of the hyperplastic epidermis stained positively with an antibody to papillomavirus group-specific antigen. Occasional neoplastic squamous epithelial cells within keratin pearls and dyskeratotic foci also exhibited faint cytoplasmic staining with an antibody to papillomavirus group-specific antigen. Intranuclear inclusion bodies consistent with papillomavirus were present in stratum granulosum cells, as in case nos. 1 and 2.

The owners elected topical retinoid therapy for the SCC because of its lower cost. The plaques within which SCC arose were treated topically using tretinoind (0.025%, approximately 25 mg, two to three times per week) for several months. Therapy was eventually discontinued by the owner because of financial constraints and lack of response. Thyroid supplementation was continued at the same dosage.

The dog was returned to the UI-VTH 1 year later. A 20 mm-diameter, ulcerative, hyperpigmented mass had developed rapidly on the upper left lip at the prior excision site of the SCC. A second, 20 mm-diameter, ulcerative plaque had also developed on the left upper lip caudal to the first one. A subcutaneous mass was palpated in the right ventral neck. The hyperkeratotic, hyperpigmented areas on the ventral abdomen persisted. Two, 10 mm-diameter, erythematous, fluctuant masses were found within the hyperpigmented area on the caudal ventral abdomen. Darkly pigmented nodules were present on the dog’s ears and the caudal aspects of both rear limbs. The masses on the lip, neck, and caudal ventral abdomen were surgically excised. Histopathological examination revealed numerous discrete and coalescing cords of moderately polymorphic squamous epithelial cells accompanied by focal areas of keratinization. Anaplasia was moderate to marked, and mitotic activity was increased. Epithelial cells had breached the basement membrane and invaded the subjacent dermal connective tissues. The microscopic diagnosis for all excised masses was SCC. Immunohistochemical labeling for papillomavirus group-specific antigen was negative.

Discussion

Plaques from the cases in this report had histopathological and ultrastructural features consistent with those of PEP.332 The ultrastructure of intranuclear inclusion bodies within epidermocytes was consistent with papillomavirus. Plaques described in this report were distinct from those of canine oral papillomavirus. Although canine oral papillomavirus can change its tissue tropism to infect skin, lesions are not hyperpigmented.3133–36 In the Pomeranian (case no. 3), the hyperkeratotic pigmented plaques on the lip developed subsequent to the cutaneous plaques, and they did not reflect a change of tropism from the oral cavity to the skin. Neither the clinical nor the histopathological appearance of the lesions was consistent with oral papillomatosis.3133–36 Likewise, lesions in this report were distinct from exophytic cutaneous papillomas, which often occur on the head, eyelid, and paws of primarily older male dogs. Exophytic papillomas are not usually pigmented and often regress spontaneously.435 Pigmented papules have been reported in a boxer with iatrogenic hyperadrenocorticism, but they differed from PEP in that they were endophytic, keratohyalin granules were rare, and both intracytoplasmic and intranuclear inclusion bodies were observed.37 The late 1 (L1) gene encodes the major capsid protein in papillomaviruses, a critical component of viral pathogenesis. Analysis of the nucleotide sequence of this gene is used to identify or compare papillomaviruses. The nucleotide sequence of the L1 open reading frame identified in the boxer’s papules was 70% homologous with that of canine oral papillomavirus, whereas PEP shares only 57% sequence homology with canine oral papillomavirus L1.3738

The study reported here documents PEP in an American Staffordshire terrier and a Pomeranian, two breeds in which PEP has not been described previously. The etiology of PEP has not yet been fully defined. Breed predisposition may reflect a genetically-determined increased susceptibility to infection by this virus or virus group, as in humans with epidermodysplasia verruciformis. Pugs and miniature schnauzers are over-represented in reports of PEP.34 The role of papillomavirus in lesions examined before the routine use of immunohistochemistry is unknown. Ideally, extant tissues from earlier cases will be reexamined.

Two cases in this report had PEP and a concurrent disease. The diagnosis of hypothyroidism in the Pomeranian was unconfirmed, and immunoglobulin levels were not measured. Impaired immune function associated with excessive cortisol production in the miniature schnauzer and low immunoglobulin levels in both the miniature schnauzer and the American Staffordshire terrier could have contributed to increased susceptibility to papillomavirus. However, direct causation of plaques by hyperadrenocorticism or immunoglobulin deficiency should not be inferred. Plaques in the miniature schnauzer failed to regress completely, despite the sharp reduction of cortisol levels induced by mitotane.

Regression and prevention of recurrence of the plaques occurred after concomitant therapy with low-dose oral human recombinant IFN-α. In the American Staffordshire terrier, plaques recurred when IFN therapy was discontinued. Low-dose oral IFN-α has been used to prevent or treat viral diseases in several species.2839–46 High doses of IFN inhibit the immune response, whereas low-dose IFN therapy stimulates immunity.4146 Orally administered IFN-α exerts both local and systemic immunostimulatory effects by binding to cell receptors associated with mucosal lymphoid tissue and acting in an autocrine and paracrine fashion to up-regulate the production of IFN-γ and additional IFN-α, ultimately leading to a systemic immune response characterized by a subset of thymic helper (Th) lymphocytes, Th1.154146 These cells produce cytokines such as inter-leukin (IL)-1, tumor necrosis factor (TNF)-β, and IFN-γ, which enhance cell-mediated immunity.154146

An alternative to oral IFN-α is topical imiquimod.g This immune modulator is an imidazoquinoline amine recently approved for topical use in humans. The drug’s antiviral and antitumor effects are caused by an induction of several cytokines that stimulate both innate and cell-mediated immunity, including IFN-α.4748 Remission has been achieved in Bowen’s disease, papillomavirus infections, and SCC in humans after topical application of imiquimod at a concentration of 5%.49–51 Imiquimod is an alternative to oral IFN-α and can be used in dermatopathies where IFN-α is effective, although its safety and efficacy in dogs have not yet been determined.5253

The association between papillomavirus infection and the development of neoplasia has been documented in several species.353642434854–59 In cats, papillomavirus infection can lead to multicentric SCC in situ (i.e., Bowen’s disease).3554–59 Mechanisms of neoplastic transformation by papillomaviruses include interference with the functions of p53 gene products, leading to decreased tumor suppression, and viral binding with retinoblastoma protein to increase cellular proliferation.2960–64

Surgical excision of SCC lesions is often curative, providing that the cancer has not metastasized.4 However, pigmented plaques are typically too numerous and widely distributed for surgical excision to be practical. Laser ablation may be a useful alternative to surgical excision, as it allows rapid removal of multiple masses and causes less tissue destruction than surgical excision.4 Laser ablation has been used palliatively in the management of multicentric SCC in cats.59 Oral and topical retinoid therapy has produced mixed results in cases of SCC in dogs.432 No improvement was observed when topical retinoids were administered in case no. 3.

Papillomavirus-associated SCC in dogs may be under-reported. Papillomavirus was not recognized at the time biopsies were initially submitted from the Pomeranian, because koilocytes were not observed, and the lesion was not evaluated by immunohistochemistry. Had the association between PEP and papillomavirus been known at the time, plaque progression might have been slowed. The drug, IFN-α, has both antiviral and antitumor properties, so its administration would have been appropriate before or after the development of SCC.3965 Identification of SCC arising within a PEP should prompt a histopathological and immunohistochemical search for papillomavirus. If an association with papillomavirus is demonstrated, the possibility of a concurrent disease state should also be investigated, and IFN-α therapy may be considered.

Conclusion

In this study, pigmented epidermal plaques were documented in an American Staffordshire terrier and a Pomeranian, two breeds in which PEP has not been described previously. Two of the dogs had concurrent disease, although the relationship between those disorders and plaque development was unclear. Plaques regressed in the two animals treated with IFN-α. Squamous cell carcinoma arose by malignant transformation from multiple plaques within the third dog. This risk of malignant transformation emphasizes the need to recognize PEP and to control plaque progression. Antiviral and antineoplastic therapy, such as low-dose oral IFN-α, may be an effective component of the therapeutic management of both PEP and papillomavirus-associated cutaneous neoplasia.

ACTHAR gel; Questcor, Union City, NJ 94587

Lysodren; Bristol-Myers Squibb, Princeton, NJ 08543

Roferon A; Hoffman-LaRoche, Nutley, NJ 07110

Staphage Lysate; Delmont Laboratories, Swarthmore, PA 19081

Retin-A; Ortho Dermatological, Raritan NJ 08869

Aldara; 3M Pharmaceuticals, Saint Paul, MN 55144

Acknowledgments

The authors thank Drs. J. Zacchary, A. Vitsky, and M. Wallig for assistance with histopathology; Drs. C. Ulbricht, S. Albright, and A. Hasty for assistance with the clinical cases; the Center for Microscopic Imaging for assistance with TEM; and the Veterinary Diagnostic Laboratory histology section for preparing histology and immunohistochemistry slides.

Figure 1—. Multiple pigmented plaques on the trunk of a miniature schnauzer with hyperadrenocorticoidism (case no. 1).Figure 1—. Multiple pigmented plaques on the trunk of a miniature schnauzer with hyperadrenocorticoidism (case no. 1).Figure 1—. Multiple pigmented plaques on the trunk of a miniature schnauzer with hyperadrenocorticoidism (case no. 1).
Figure 1 Multiple pigmented plaques on the trunk of a miniature schnauzer with hyperadrenocorticoidism (case no. 1).

Citation: Journal of the American Animal Hospital Association 40, 5; 10.5326/0400411

Figure 2—. Histopathological section (from case no. 1) of an exophytic plaque with papillomatous projections (Hematoxylin and eosin stain; 50×).Figure 2—. Histopathological section (from case no. 1) of an exophytic plaque with papillomatous projections (Hematoxylin and eosin stain; 50×).Figure 2—. Histopathological section (from case no. 1) of an exophytic plaque with papillomatous projections (Hematoxylin and eosin stain; 50×).
Figure 2 Histopathological section (from case no. 1) of an exophytic plaque with papillomatous projections (Hematoxylin and eosin stain; 50×).

Citation: Journal of the American Animal Hospital Association 40, 5; 10.5326/0400411

Figure 3—. Transmission electron microscope image of hexagonal viral particles within an intranuclear inclusion body from case no. 1 (33,000×).Figure 3—. Transmission electron microscope image of hexagonal viral particles within an intranuclear inclusion body from case no. 1 (33,000×).Figure 3—. Transmission electron microscope image of hexagonal viral particles within an intranuclear inclusion body from case no. 1 (33,000×).
Figure 3 Transmission electron microscope image of hexagonal viral particles within an intranuclear inclusion body from case no. 1 (33,000×).

Citation: Journal of the American Animal Hospital Association 40, 5; 10.5326/0400411

Figure 4—. Histopathological section through an area of squamous cell carcinoma from case no. 3, showing keratin pearls and neoplastic epidermocytes within the dermis (Hematoxylin and eosin stain; 100×).Figure 4—. Histopathological section through an area of squamous cell carcinoma from case no. 3, showing keratin pearls and neoplastic epidermocytes within the dermis (Hematoxylin and eosin stain; 100×).Figure 4—. Histopathological section through an area of squamous cell carcinoma from case no. 3, showing keratin pearls and neoplastic epidermocytes within the dermis (Hematoxylin and eosin stain; 100×).
Figure 4 Histopathological section through an area of squamous cell carcinoma from case no. 3, showing keratin pearls and neoplastic epidermocytes within the dermis (Hematoxylin and eosin stain; 100×).

Citation: Journal of the American Animal Hospital Association 40, 5; 10.5326/0400411

Footnotes

    Doctor Stokking’s current address is the VCA Emergency Animal Hospital and Referral Center, 2317 Hotel Circle South, San Diego, California 92108. Doctor Ehrhart’s current address is the Department of Microbiology, Immunology, and Pathology; Colorado State University, Fort Collins, Colorado 80523.

References

  • 1
    Briggs OM. Lentiginosis profusa in the pug: three case reports. J Small Anim Pract 1985;26:675–680.
  • 2
    Rensburg IBJ, Briggs OM. Pathology of canine lentiginosis profusa. J S Afric Vet Med Assoc 1986;57:159–161.
  • 3
    Nagata M, Nanko H, Moriyama A, et al. Pigmented plaques associated with papillomavirus infection in dogs: is this epidermodysplasia verruciformis? Vet Derm 1995;6:179–186.
  • 4
    Scott D, Miller W Jr, Griffin C. Muller & Kirk’s Small Animal Dermatology. 6th ed. Philadelphia: WB Saunders, 1997:853–854.
  • 5
    Walder EJ. Malignant transformation of a pigmented epidermal nevus in a dog. Vet Pathol 1997;34:505.
  • 6
    Elder D, Elenitsas R. Benign pigmented lesions and malignant melanoma. In: Elder D, ed. Lever’s Histopathology of the Skin. 8th ed. Philadelphia: Lippincott-Raven, 1997:625–684.
  • 7
    Antonsson A, Forslund O, Ekberg H, et al. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000;74:11636–11641.
  • 8
    Berkhout RJ, Tieber LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant patients. J Clin Microbiol 1995;33:690–695.
  • 9
    Boxman IL, Russell A, Mulder LHC, et al. Association between epidermodysplasia verruciformis-associated papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol 2001;117:1108–1112.
  • 10
    Chan S-Y, Bernard H-U, Ong C-K, et al. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol 1992;66:5714–5725.
  • 11
    Chan S-Y, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 1995;69:3074–3083.
  • 12
    Deau MC, Favre M, Orth G. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virol 1991;184:492–503.
  • 13
    Favre M, Orth G, Majewski S, et al. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1994;110:311–317.
  • 14
    Gassenmaier A, Lammel M, Pfister H. Molecular cloning and characterization of the DNAs of human papillomaviruses 19, 20, and 25 from a patient with epidermodysplasia verruciformis. J Virol 1984;52:1019–1023.
  • 15
    Gilger BC, Rose PD, Davidson MG, et al. Low-dose oral administration of interferon-α for the treatment of immune-mediated keratoconjunctivitis sicca in dogs. J Interferon Cytokine Res 1999;19:901–905.
  • 16
    Kremsdorf D, Favre M, Jablonska S, et al. Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol 1984;52:1013–1018.
  • 17
    Kremsdorf D, Jablonska S, Favre M, et al. Biochemical characterization of two types of human papillomaviruses associated with epidermodysplasia verruciformis. J Virol 1982;43:436–447.
  • 18
    Kremsdorf D, Jablonska S, Favre M, et al. Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomaviruses 3a, 8, 10, and 12 genomes. J Virol 1983;48:340–351.
  • 19
    Obalek S, Favre M, Szymanczyk J, et al. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. J Invest Dermatol 1992;98:936–941.
  • 20
    Orth G, Favre M, Majewski S, et al. Epidermodysplasia verruciformis defines a subset of cutaneous human papillomaviruses. J Virol 2001;75:10,4952–10,4953.21.
  • 21
    Schiffman MH, Burk RD. Human papillomaviruses. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans. 4th ed. New York: Plenum Medical Book Company, 1997:983–1023.
  • 22
    Ramoz N, Taieb A, Rueda L-A, et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21–p24 and 17q25. J Invest Dermatol 2000;114:1148–1153.
  • 23
    Majewski S, Breitburd F, Skopinska M, et al. A mouse model for studying epidermodysplasia-verruciformis-associated carcinogenesis. Int J Cancer 1994;56:727–730.
  • 24
    Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance. Am J Med Sci 1992;304:174–179.
  • 25
    Majewski S, Malejczyk M, Jablonska S, et al. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1989;22:423–427.
  • 26
    Majewski S, Skopinski-Rozewska E, Jablonska S, et al. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986;15:966–973.
  • 27
    Arany I, Tyring SK. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions. J Interferon Cytokine Res 1996;16:453–460.
  • 28
    Gross G, Ellinger K, Roussake A, et al. Epidermodysplasia verruciformis in a patient with Hodgkin’s disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol 1988;91:43–48.
  • 29
    Padlewska K, Ramoz N, Cassonnet P, et al. Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis. J Invest Dermatol 2001;117:935–942.
  • 30
    Favre M, Majewski S, Noszczyk S, et al. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 2000;114:403–407.
  • 31
    Sundberg JP. Canine papillomaviruses. In: Castro E, Herschel WP, eds. Veterinary Diagnostic Virology: A Practitioner’s Guide. St. Louis: Mosby-Year Book, 1992:148.
  • 32
    Gottlieb SL, Hayes E, Gilleaudeau P, et al. Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes. J Cut Pathol 1996;23:404–418.
  • 33
    Sundberg JP, Smith EK, Herron AJ, et al. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese shar pei dog. Vet Pathol 1994;31:183–187.
  • 34
    Walder EJ. Pigmented epidermal nevus. In: Gross TL, Ihrke PJ, Walder EJ, eds. Veterinary Dermatopathology: A Macroscopic and Microscopic Evaluation of Canine and Feline Skin Disease. St. Louis: Mosby-Year Book, 1992:331–332.
  • 35
    Walder EJ. Viral squamous papilloma. In: Gross TL, Ihrke PJ, Walder EJ, eds. Veterinary Dermatopathology: A Macroscopic and Microscopic Evaluation of Canine and Feline Skin Disease. St. Louis: Mosby-Year Book, 1992:334–335.
  • 36
    Bregman CL, Hirth RS, Sundberg JP, et al. Cutaneous neoplasms in dogs associated with canine oral papillomavirus vaccine. Vet Pathol 1987;24:477–487.
  • 37
    Le Net JL, Orth G, Sundberg JP, et al. Multiple pigmented cutaneous papules associated with a novel canine papillomavirus in an immunosuppressed dog. Vet Pathol 1997;34:8–14.
  • 38
    Tanabe C, Kano R, Nagata M, et al. Molecular characteristics of cutaneous papillomavirus from the canine pigmented epidermal nevus. J Vet Med Sci 2000;62:1189–1192.
  • 39
    Brinkman V, Geiger T, Alkan S, et al. Interferon α increases the frequency of interferon γ-producing human CD4+ T cells. J Exp Med 1993;178:1655–1663.
  • 40
    Tateyama S, Priosoeryanto BP, Yamaguchi R, et al. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumors. Res Vet Sci 1995;59:275–277.
  • 41
    Tompkins W. Immunomodulation and therapeutic effects of the oral use of interferon α: mechanism of action. J Interferon Cytokine Res 1999;19:817–828.
  • 42
    Penneys N. Diseases caused by viruses. In: Elder D, ed. Lever’s Histopathology of the Skin. 8th ed. Philadelphia: Lippincott-Raven, 1997:569–589.
  • 43
    Rockley PF, Tyring SK. Interferon α, β, and γ therapy of anogenital human papillomavirus infections. Pharm Ther 1995;65:265–287.
  • 44
    Tizard I. Uses of biological response modifiers. Vet Aller Clin Immunol 1995;3:51–57.
  • 45
    Van Kampen KR. Immunomodulators – the hopes, expectations, and reality. Vet Aller Clin Immunol 1995;3:123–127.
  • 46
    Fleischmann WR Jr, Koren S. Systemic effects of orally administered interferons and IL-2. J Interferon Cytokine Res 1999;19:829–839.
  • 47
    Gupta AK, Browne M, Bluhm R. Imiquimod: a review. J Cut Med Surg 2002;6:554–560.
  • 48
    Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000;43:S6–11.
  • 49
    Gutzmer R, Kaspar M, Vogelbrunch M, et al. Successful treatment of anogenital Bowen’s disease with the immunomodulator imiquimod and monitoring of treatment by DNA image cytometry. Br J Dermatol 2002;147:160–165.
  • 50
    Kaspari M, Gutzmer R, Kiehl P, et al. Erythroplasia of Queyrat: human papillomavirus-associated carcinoma in situ of the penis. Dermatol 2002;205:67–69.
  • 51
    Orengo I, Rosen T, Guill CK. Treatment of squamous cell carcinoma of the penis with 5% imiquimod cream: a case report. J Am Acad Dermatol 2002;47:S225–228.
  • 52
    Tyring S. Imiquimod applied topically: a novel immune response modifier. Skin Ther Lett 2001;6:1–4.
  • 53
    Tyring S, Conant M, Marini M, et al. Imiquimod: an international update on therapeutic uses in dermatology. Int J Dermatol 2002;41:810–816.
  • 54
    Kirkham N. Tumors and cysts of the epidermis. In: Elder D, ed. Lever’s Histopathology of the Skin. 8th ed. Philadelphia: Lippincott-Raven, 1997:685–746.
  • 55
    Baer KE, Helton K. Multicentric squamous cell carcinoma in situ resembling Bowen’s disease in cats. Vet Pathol 1993;30:535–543.
  • 56
    Le Clerc SM, Clark EG, Haines DH. Papillomavirus infections in association with feline cutaneous squamous cell carcinoma in situ. 13th Proc AAVD/ACVD, 1997:125–126.
  • 57
    Miller WH, Affolter V, Scott DW, et al. Multicentric squamous cell carcinoma in situ resembling Bowen’s disease in five cats. Vet Dermatol 1992;3:177–182.
  • 58
    Turrel JM, Gross TL. Multicentric squamous cell carcinoma in situ (Bowen’s disease) of cats. Proc 11th Ann Conf Vet Cancer Soc, 1991:84.
  • 59
    Stokking LB, Campbell KL. Bowen’s disease (multicentric squamous cell carcinoma in situ). In: August JR, ed. Consultations in Feline Internal Medicine. 2001;4:208–213.
  • 60
    Teifke JP, Lohr CV. Immunohistochemical detection of p53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats, and dogs. J Comp Pathol 1996;114:205–210.
  • 61
    Teifke JP, Lohr CV, Shirasawa H. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Vet Microbiol 1998;60:119–130.
  • 62
    Teifke JP, Lohr CV, Shirasawa H. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas in the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Vet Microbiol 1998;60:119–130.
  • 63
    Werness BA, Levine AJ, Howley P. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;24X:76–79.
  • 64
    Schmitt A, Harry JB, Rapp B, et al. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol 1994;68:7051–7059.
  • 65
    Belardelli F, Gresser I. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunology Today 1996;17:369–372.
Copyright: Copyright 2004 by The American Animal Hospital Association 2004
<bold>
  <italic toggle="yes">Figure 1</italic>
</bold>
—
Figure 1

Multiple pigmented plaques on the trunk of a miniature schnauzer with hyperadrenocorticoidism (case no. 1).


<bold>
  <italic toggle="yes">Figure 2</italic>
</bold>
—
Figure 2

Histopathological section (from case no. 1) of an exophytic plaque with papillomatous projections (Hematoxylin and eosin stain; 50×).


<bold>
  <italic toggle="yes">Figure 3</italic>
</bold>
—
Figure 3

Transmission electron microscope image of hexagonal viral particles within an intranuclear inclusion body from case no. 1 (33,000×).


<bold>
  <italic toggle="yes">Figure 4</italic>
</bold>
—
Figure 4

Histopathological section through an area of squamous cell carcinoma from case no. 3, showing keratin pearls and neoplastic epidermocytes within the dermis (Hematoxylin and eosin stain; 100×).


  • Download PDF